RISPERIDONE

RISPERIDONE was reported 75396 times

These side effects are most commonly reported by patients taking RISPERIDONE:

# Side effect Count
0 GYNAECOMASTIA 24656
1 OFF LABEL USE 12590
2 ABNORMAL WEIGHT GAIN 9459
3 WEIGHT INCREASED 9289
4 DRUG INEFFECTIVE 7795
5 PRODUCT USE IN UNAPPROVED INDICATION 6038
6 EMOTIONAL DISORDER 5963
7 INJURY 4643
8 DRUG INTERACTION 4599
9 HYPERPROLACTINAEMIA 4514
10 SOMNOLENCE 4490
11 GALACTORRHOEA 3786
12 OBESITY 3722
13 EMOTIONAL DISTRESS 3540
14 EXTRAPYRAMIDAL DISORDER 3489
15 ANXIETY 3304
16 CONDITION AGGRAVATED 3219
17 SUICIDE ATTEMPT 3141
18 FATIGUE 3098
19 FALL 2874
20 DIABETES MELLITUS 2837
21 AGGRESSION 2812
22 INSOMNIA 2812
23 PRODUCT USE ISSUE 2812
24 PSYCHOTIC DISORDER 2802
25 TREATMENT NONCOMPLIANCE 2778
26 DEPRESSION 2701
27 SUICIDAL IDEATION 2692
28 TOXICITY TO VARIOUS AGENTS 2681
29 TREMOR 2598
30 NAUSEA 2531
31 SEDATION 2529
32 CONFUSIONAL STATE 2498
33 AGITATION 2467
34 VOMITING 2450
35 DEATH 2418
36 NEUROLEPTIC MALIGNANT SYNDROME 2265
37 OVERDOSE 2261
38 DIZZINESS 2221
39 SCHIZOPHRENIA 2166
40 HYPOTENSION 2126
41 DRUG DOSE OMISSION 2112
42 HEADACHE 2104
43 DYSKINESIA 2046
44 DYSPNOEA 2023
45 PYREXIA 1926
46 INTENTIONAL OVERDOSE 1871
47 TYPE 2 DIABETES MELLITUS 1859
48 TACHYCARDIA 1791
49 TARDIVE DYSKINESIA 1760
50 DYSTONIA 1758
51 COMPLETED SUICIDE 1747
52 MALAISE 1737
53 HALLUCINATION, AUDITORY 1718
54 PNEUMONIA 1717
55 DIARRHOEA 1710
56 HOSPITALISATION 1694
57 ASTHENIA 1677
58 ADVERSE EVENT 1673
59 AKATHISIA 1672
60 CONSTIPATION 1635
61 ABNORMAL BEHAVIOUR 1631
62 PAIN 1614
63 HALLUCINATION 1592
64 HYPERTENSION 1575
65 BLOOD PROLACTIN INCREASED 1559
66 WEIGHT DECREASED 1447
67 FEELING ABNORMAL 1409
68 SEIZURE 1390
69 GAIT DISTURBANCE 1348
70 PRODUCT DOSE OMISSION ISSUE 1225
71 RESTLESSNESS 1223
72 DELIRIUM 1219
73 HYPERGLYCAEMIA 1214
74 ELECTROCARDIOGRAM QT PROLONGED 1199
75 LOSS OF CONSCIOUSNESS 1198
76 DEPRESSED LEVEL OF CONSCIOUSNESS 1192
77 COMA 1191
78 ACUTE KIDNEY INJURY 1190
79 DYSPHAGIA 1185
80 DRUG ABUSE 1163
81 BLOOD GLUCOSE INCREASED 1161
82 DELUSION 1160
83 PARKINSONISM 1155
84 RHABDOMYOLYSIS 1152
85 GENERAL PHYSICAL HEALTH DETERIORATION 1100
86 HYPONATRAEMIA 1091
87 NEUTROPENIA 1089
88 IRRITABILITY 1088
89 DECREASED APPETITE 1072
90 INTENTIONAL SELF-INJURY 1063
91 PARANOIA 1059
92 INCREASED APPETITE 1051
93 DEVICE LEAKAGE 1042
94 RASH 1040
95 CHEST PAIN 1028
96 HYPERHIDROSIS 1025
97 DISTURBANCE IN ATTENTION 1004
98 ABDOMINAL PAIN 989
99 INCORRECT DOSE ADMINISTERED 989
100 MEMORY IMPAIRMENT 975
101 ADVERSE DRUG REACTION 972
102 PULMONARY EMBOLISM 964
103 BLOOD CREATINE PHOSPHOKINASE INCREASED 954
104 DEVICE MALFUNCTION 946
105 LEUKOPENIA 940
106 URINARY TRACT INFECTION 940
107 DEHYDRATION 933
108 MUSCULOSKELETAL STIFFNESS 915
109 BLOOD CHOLESTEROL INCREASED 903
110 SPEECH DISORDER 897
111 MEDICATION ERROR 885
112 SEXUAL DYSFUNCTION 882
113 SALIVARY HYPERSECRETION 874
114 COGNITIVE DISORDER 871
115 DYSARTHRIA 865
116 MUSCLE RIGIDITY 863
117 VISION BLURRED 861
118 MENTAL DISORDER 853
119 CATATONIA 843
120 RENAL FAILURE 843
121 PNEUMONIA ASPIRATION 836
122 MANIA 829
123 CONVULSION 808
124 PANCREATITIS 800
125 PAIN IN EXTREMITY 799
126 LETHARGY 793
127 OEDEMA PERIPHERAL 792
128 SYNCOPE 790
129 ANAEMIA 784
130 BRADYCARDIA 776
131 THROMBOCYTOPENIA 774
132 URINARY INCONTINENCE 769
133 CARDIAC ARREST 766
134 COUGH 758
135 ACCIDENTAL EXPOSURE TO PRODUCT 751
136 ARTHRALGIA 747
137 METABOLIC DISORDER 741
138 MUSCLE SPASMS 741
139 BACK PAIN 733
140 INTENTIONAL PRODUCT MISUSE 722
141 PRODUCT QUALITY ISSUE 707
142 SEROTONIN SYNDROME 703
143 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 692
144 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 674
145 PRURITUS 671
146 SLEEP DISORDER 671
147 URINARY RETENTION 669
148 CEREBROVASCULAR ACCIDENT 667
149 DISORIENTATION 664
150 HYPOTHERMIA 658
151 MENTAL IMPAIRMENT 651
152 HALLUCINATION, VISUAL 645
153 HEART RATE INCREASED 644
154 MYOCARDIAL INFARCTION 641
155 ALTERED STATE OF CONSCIOUSNESS 638
156 AMNESIA 635
157 SYRINGE ISSUE 632
158 BALANCE DISORDER 620
159 ANGER 618
160 WITHDRAWAL SYNDROME 617
161 PALPITATIONS 614
162 UNDERDOSE 607
163 HYPOGLYCAEMIA 600
164 ABDOMINAL PAIN UPPER 594
165 BLOOD TRIGLYCERIDES INCREASED 594
166 BLOOD PRESSURE INCREASED 588
167 WHITE BLOOD CELL COUNT DECREASED 588
168 SOPOR 586
169 PSYCHOMOTOR HYPERACTIVITY 585
170 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 584
171 OVERWEIGHT 583
172 DEEP VEIN THROMBOSIS 582
173 ALANINE AMINOTRANSFERASE INCREASED 575
174 CARDIO-RESPIRATORY ARREST 567
175 DEPRESSED MOOD 567
176 RENAL IMPAIRMENT 567
177 ERECTILE DYSFUNCTION 564
178 AMENORRHOEA 563
179 HYPOAESTHESIA 557
180 SELF INJURIOUS BEHAVIOUR 549
181 DISTURBANCE IN SOCIAL BEHAVIOUR 547
182 HYPERSOMNIA 546
183 BLOOD PROLACTIN ABNORMAL 545
184 MUSCULAR WEAKNESS 545
185 OBSESSIVE-COMPULSIVE DISORDER 544
186 SEPSIS 543
187 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 539
188 DIABETIC KETOACIDOSIS 537
189 EPILEPSY 535
190 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 535
191 THERAPY CESSATION 535
192 TREATMENT FAILURE 530
193 ALOPECIA 527
194 PERSONALITY CHANGE 521
195 THINKING ABNORMAL 518
196 DRUG HYPERSENSITIVITY 513
197 DRY MOUTH 506
198 DRUG INTOLERANCE 504
199 HYPERSENSITIVITY 500
200 HEPATIC ENZYME INCREASED 494
201 FOETAL EXPOSURE DURING PREGNANCY 493
202 MENTAL STATUS CHANGES 491
203 GASTROOESOPHAGEAL REFLUX DISEASE 483
204 PLATELET COUNT DECREASED 482
205 SINUS TACHYCARDIA 482
206 HYPOKALAEMIA 477
207 INFECTION 474
208 VISUAL IMPAIRMENT 473
209 ARRHYTHMIA 472
210 ASPARTATE AMINOTRANSFERASE INCREASED 467
211 NEUROPATHY PERIPHERAL 467
212 BLOOD PRESSURE DECREASED 466
213 BREAST ENLARGEMENT 466
214 MYALGIA 465
215 HAEMOGLOBIN DECREASED 460
216 DEMENTIA 459
217 DROOLING 457
218 NEEDLE ISSUE 457
219 DIABETES MELLITUS INADEQUATE CONTROL 454
220 PRODUCT DOSE OMISSION 454
221 CHOLELITHIASIS 451
222 HYPERLIPIDAEMIA 451
223 ANOSOGNOSIA 447
224 PARAESTHESIA 446
225 OCULOGYRIC CRISIS 445
226 DRUG WITHDRAWAL SYNDROME 444
227 ORTHOSTATIC HYPOTENSION 444
228 RESPIRATORY FAILURE 443
229 APATHY 440
230 CARDIAC FAILURE 435
231 APHASIA 429
232 MUSCLE TWITCHING 429
233 BLOOD CREATININE INCREASED 426
234 ACCIDENTAL OVERDOSE 416
235 WHITE BLOOD CELL COUNT INCREASED 413
236 THERAPEUTIC RESPONSE DECREASED 411
237 MYOCARDITIS 409
238 CARDIAC DISORDER 403
239 METABOLIC ACIDOSIS 403
240 ABDOMINAL DISTENSION 401
241 MOVEMENT DISORDER 400
242 ATRIAL FIBRILLATION 397
243 PANCYTOPENIA 395
244 DRUG ADMINISTRATION ERROR 394
245 UNRESPONSIVE TO STIMULI 392
246 C-REACTIVE PROTEIN INCREASED 391
247 DRUG DEPENDENCE 388
248 TIC 385
249 BIPOLAR DISORDER 382
250 NASOPHARYNGITIS 382
251 ABDOMINAL DISCOMFORT 381
252 MOOD SWINGS 377
253 THERAPY NON-RESPONDER 374
254 EATING DISORDER 373
255 INJECTION SITE PAIN 373
256 CONTUSION 372
257 ERYTHEMA 372
258 PRIAPISM 372
259 UNEVALUABLE EVENT 372
260 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 367
261 NIGHTMARE 366
262 PRESCRIBED OVERDOSE 358
263 CRYING 356
264 EXPOSURE DURING PREGNANCY 356
265 TYPE 1 DIABETES MELLITUS 356
266 STRESS 354
267 RENAL FAILURE ACUTE 353
268 WRONG TECHNIQUE IN DRUG USAGE PROCESS 348
269 CHRONIC KIDNEY DISEASE 347
270 DIABETIC NEUROPATHY 346
271 PANIC ATTACK 345
272 LIVER FUNCTION TEST ABNORMAL 339
273 DYSPEPSIA 337
274 NO ADVERSE EVENT 336
275 NERVOUSNESS 335
276 PSYCHIATRIC DECOMPENSATION 330
277 SUDDEN DEATH 327
278 SLUGGISHNESS 323
279 CHILLS 319
280 LEUKOCYTOSIS 319
281 FEAR 317
282 PERIPHERAL SWELLING 317
283 PSYCHOTIC SYMPTOM 316
284 URTICARIA 315
285 HYPERTHERMIA 314
286 HYPOMANIA 314
287 GASTROINTESTINAL DISORDER 312
288 HEAD INJURY 311
289 ASTHMA 309
290 ATAXIA 306
291 ENCEPHALOPATHY 306
292 INFLUENZA 306
293 HEPATIC FUNCTION ABNORMAL 304
294 INTESTINAL OBSTRUCTION 304
295 COVID-19 303
296 DRUG LEVEL INCREASED 299
297 VERTIGO 299
298 AFFECTIVE DISORDER 298
299 DISEASE RECURRENCE 298
300 RESPIRATORY DEPRESSION 298
301 MOOD ALTERED 297
302 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 296
303 MATERNAL EXPOSURE DURING PREGNANCY 296
304 SCHIZOAFFECTIVE DISORDER 296
305 SOCIAL AVOIDANT BEHAVIOUR 293
306 OXYGEN SATURATION DECREASED 290
307 PSYCHIATRIC SYMPTOM 290
308 MOBILITY DECREASED 288
309 MYOCLONUS 287
310 EUPHORIC MOOD 285
311 HEPATOTOXICITY 285
312 BLOOD BILIRUBIN INCREASED 284
313 HYPOTHYROIDISM 284
314 PERSECUTORY DELUSION 284
315 PSYCHOMOTOR SKILLS IMPAIRED 283
316 OEDEMA 282
317 CHEST DISCOMFORT 280
318 SHOCK 280
319 NEUTROPHIL COUNT DECREASED 279
320 GENERALISED TONIC-CLONIC SEIZURE 278
321 RESPIRATORY ARREST 278
322 RESPIRATORY DISTRESS 278
323 ANHEDONIA 277
324 PANCREATITIS ACUTE 275
325 SEDATION COMPLICATION 275
326 SWELLING 275
327 CELLULITIS 274
328 NERVOUS SYSTEM DISORDER 269
329 AGRANULOCYTOSIS 267
330 INCONTINENCE 267
331 PLEURAL EFFUSION 267
332 PSYCHOMOTOR RETARDATION 266
333 BRONCHITIS 265
334 DIABETIC COMA 265
335 GASTROINTESTINAL HAEMORRHAGE 265
336 POLLAKIURIA 265
337 PRODUCT SUBSTITUTION ISSUE 265
338 EPISTAXIS 264
339 HEPATIC STEATOSIS 264
340 DRUG RESISTANCE 263
341 DEVICE ISSUE 262
342 DYSLIPIDAEMIA 262
343 LIVER DISORDER 261
344 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 259
345 BEHAVIOUR DISORDER 257
346 LACTIC ACIDOSIS 257
347 MIOSIS 256
348 CARDIAC FAILURE CONGESTIVE 255
349 GAMMA-GLUTAMYLTRANSFERASE INCREASED 254
350 PULMONARY OEDEMA 252
351 SLEEP APNOEA SYNDROME 252
352 DISEASE PROGRESSION 251
353 DYSURIA 251
354 RENAL DISORDER 251
355 BRAIN INJURY 249
356 MAJOR DEPRESSION 249
357 POISONING DELIBERATE 249
358 SWELLING FACE 247
359 DEPRESSIVE SYMPTOM 246
360 HOMICIDAL IDEATION 246
361 WRONG PATIENT RECEIVED PRODUCT 246
362 COGWHEEL RIGIDITY 245
363 DRUG-INDUCED LIVER INJURY 245
364 RESTLESS LEGS SYNDROME 245
365 MIGRAINE 244
366 HAEMORRHAGE 242
367 POISONING 242
368 DRUG EXPOSURE DURING PREGNANCY 241
369 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 241
370 OROPHARYNGEAL PAIN 241
371 POLYDIPSIA 241
372 HYPOXIA 240
373 BLOOD SODIUM DECREASED 239
374 HEPATITIS 239
375 HAEMATOCRIT DECREASED 238
376 HYPOTONIA 238
377 SINUS BRADYCARDIA 238
378 REFUSAL OF TREATMENT BY PATIENT 237
379 DRUG EFFECT DECREASED 233
380 HYPOKINESIA 233
381 TACHYPNOEA 233
382 HEPATOCELLULAR INJURY 231
383 HYPERTONIA 231
384 HYPOPHAGIA 231
385 PRODUCT ADMINISTRATION ERROR 230
386 ANTICHOLINERGIC SYNDROME 229
387 LIBIDO DECREASED 229
388 WHEEZING 229
389 PLEUROTHOTONUS 227
390 DISINHIBITION 226
391 DYSPHONIA 224
392 HYPERKALAEMIA 224
393 METABOLIC SYNDROME 224
394 NECK PAIN 224
395 BRADYKINESIA 223
396 EYE MOVEMENT DISORDER 222
397 NEUTROPHIL COUNT INCREASED 222
398 DEVICE BREAKAGE 221
399 HALLUCINATIONS, MIXED 221
400 MULTIPLE DRUG OVERDOSE INTENTIONAL 220
401 BREAST DISCHARGE 218
402 STUPOR 218
403 SWOLLEN TONGUE 217
404 DRUG TOXICITY 216
405 GLUCOSE TOLERANCE IMPAIRED 216
406 HYPERPHAGIA 216
407 ILLNESS 216
408 DYSSTASIA 215
409 THROMBOSIS 215
410 DRUG PRESCRIBING ERROR 213
411 ENURESIS 212
412 TRANSAMINASES INCREASED 212
413 BURNING SENSATION 211
414 MYDRIASIS 211
415 PRODUCT PRESCRIBING ERROR 211
416 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 210
417 INTENTIONAL PRODUCT USE ISSUE 209
418 CIRCULATORY COLLAPSE 208
419 RESPIRATORY DISORDER 208
420 TEARFULNESS 208
421 DEVICE OCCLUSION 207
422 CHOKING 205
423 JAUNDICE CHOLESTATIC 205
424 WRONG PRODUCT ADMINISTERED 205
425 BLOOD ALKALINE PHOSPHATASE INCREASED 204
426 BLINDNESS 202
427 ROAD TRAFFIC ACCIDENT 202
428 HAEMATOMA 201
429 LUNG DISORDER 201
430 GRANULOCYTOPENIA 197
431 HEPATIC CYTOLYSIS 197
432 TINNITUS 197
433 CHOLESTASIS 196
434 NASAL CONGESTION 194
435 STATUS EPILEPTICUS 193
436 LIVER INJURY 191
437 SEPTIC SHOCK 191
438 ANTIPSYCHOTIC DRUG LEVEL INCREASED 190
439 MOTOR DYSFUNCTION 190
440 ANGIOEDEMA 189
441 ELECTROCARDIOGRAM ABNORMAL 189
442 STAPHYLOCOCCAL INFECTION 189
443 ABASIA 188
444 CATARACT 188
445 INCOHERENT 188
446 BODY TEMPERATURE INCREASED 187
447 ACTIVITIES OF DAILY LIVING IMPAIRED 186
448 JOINT SWELLING 185
449 SINUSITIS 185
450 HYPERCHOLESTEROLAEMIA 184
451 MUSCULOSKELETAL PAIN 184
452 SCREAMING 184
453 GRAND MAL CONVULSION 183
454 POOR QUALITY SLEEP 183
455 EMOTIONAL POVERTY 181
456 ILL-DEFINED DISORDER 181
457 CARDIAC MURMUR 178
458 BREAST PAIN 177
459 ASPIRATION 176
460 LOGORRHOEA 176
461 OSTEOPOROSIS 176
462 UPPER RESPIRATORY TRACT INFECTION 176
463 BRADYPHRENIA 175
464 PALLOR 175
465 STEVENS-JOHNSON SYNDROME 175
466 THIRST 175
467 TORTICOLLIS 175
468 WOUND 175
469 BEDRIDDEN 174
470 PARKINSON^S DISEASE 174
471 RECTAL HAEMORRHAGE 173
472 BREAST CANCER 172
473 CARDIOVASCULAR DISORDER 172
474 COMMUNICATION DISORDER 172
475 DISCOMFORT 172
476 FLATULENCE 172
477 RHINORRHOEA 172
478 TORSADE DE POINTES 172
479 COORDINATION ABNORMAL 171
480 ACNE 170
481 AFFECT LABILITY 169
482 DEPRESSION SUICIDAL 169
483 HUNGER 169
484 IMPAIRED WORK ABILITY 169
485 CEREBRAL INFARCTION 167
486 GASTRITIS 167
487 EOSINOPHILIA 165
488 POLYURIA 164
489 ACUTE RESPIRATORY FAILURE 162
490 CYANOSIS 162
491 LYMPHOCYTE COUNT DECREASED 162
492 TRANSIENT ISCHAEMIC ATTACK 162
493 PITUITARY TUMOUR BENIGN 161
494 PSORIASIS 161
495 ARTHRITIS 159
496 EYE PAIN 159
497 INJURY ASSOCIATED WITH DEVICE 159
498 BRAIN OEDEMA 158
499 FAECALOMA 158
500 HAEMATOCHEZIA 158
501 INJECTION SITE NODULE 158
502 ELECTROLYTE IMBALANCE 157
503 JAUNDICE 157
504 THERAPEUTIC PRODUCT EFFECT DECREASED 157
505 THERAPY PARTIAL RESPONDER 157
506 FLUSHING 156
507 HAEMATURIA 156
508 IMPULSIVE BEHAVIOUR 155
509 FEELING HOT 154
510 GESTATIONAL DIABETES 154
511 HEART RATE DECREASED 154
512 ILEUS PARALYTIC 153
513 GLYCOSYLATED HAEMOGLOBIN INCREASED 152
514 STARING 152
515 ABNORMAL DREAMS 151
516 CARDIOMYOPATHY 151
517 INCORRECT ROUTE OF DRUG ADMINISTRATION 151
518 RED BLOOD CELL COUNT DECREASED 151
519 CONTRAINDICATED PRODUCT ADMINISTERED 149
520 HYPERAMMONAEMIC ENCEPHALOPATHY 149
521 THERAPEUTIC RESPONSE UNEXPECTED 149
522 BLISTER 148
523 DRY SKIN 148
524 EYE DISORDER 148
525 FOREIGN BODY 148
526 THERAPEUTIC PRODUCT EFFECT VARIABLE 147
527 MUTISM 146
528 SELF-INJURIOUS IDEATION 146
529 HYPERTRIGLYCERIDAEMIA 145
530 SKIN DISCOLOURATION 145
531 SUBSTANCE ABUSE 145
532 LOSS OF LIBIDO 144
533 SKIN EXFOLIATION 144
534 FLUID RETENTION 143
535 MULTIPLE DRUG OVERDOSE 143
536 OROMANDIBULAR DYSTONIA 143
537 PERICARDIAL EFFUSION 143
538 HAEMATEMESIS 142
539 HAEMODYNAMIC INSTABILITY 142
540 HEPATIC FAILURE 142
541 BLOOD POTASSIUM DECREASED 141
542 INTERNATIONAL NORMALISED RATIO INCREASED 141
543 DISABILITY 140
544 HYPERAMMONAEMIA 140
545 PARADOXICAL DRUG REACTION 140
546 ACUTE PSYCHOSIS 139
547 ECONOMIC PROBLEM 139
548 ANGINA PECTORIS 138
549 ASPHYXIA 138
550 DIPLOPIA 138
551 PRODUCT PHYSICAL ISSUE 138
552 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 138
553 DRUG ERUPTION 137
554 INFLUENZA LIKE ILLNESS 137
555 LUNG NEOPLASM MALIGNANT 137
556 RASH MACULO-PAPULAR 137
557 VISUAL ACUITY REDUCED 136
558 OSTEOARTHRITIS 135
559 RENAL INJURY 135
560 RHINITIS ALLERGIC 135
561 VENTRICULAR EXTRASYSTOLES 135
562 ACUTE RESPIRATORY DISTRESS SYNDROME 134
563 ABORTION SPONTANEOUS 133
564 CEREBRAL HAEMORRHAGE 133
565 FACE OEDEMA 133
566 HYPERNATRAEMIA 133
567 INFLAMMATION 133
568 NEPHROLITHIASIS 133
569 CARDIOGENIC SHOCK 132
570 EXPOSURE TO CONTAMINATED DEVICE 132
571 INTENTIONAL DRUG MISUSE 132
572 CEREBRAL ATROPHY 131
573 CORONARY ARTERY DISEASE 131
574 SURGERY 131
575 AUTISM SPECTRUM DISORDER 130
576 BREAST DISORDER 130
577 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 130
578 INTERSTITIAL LUNG DISEASE 129
579 THERAPEUTIC RESPONSE SHORTENED 129
580 DRY EYE 128
581 GAIT INABILITY 128
582 DRUG EFFECT INCOMPLETE 127
583 HEART RATE IRREGULAR 127
584 LOWER RESPIRATORY TRACT INFECTION 127
585 MULTIPLE ORGAN DYSFUNCTION SYNDROME 127
586 ANOREXIA 126
587 BLOOD UREA INCREASED 126
588 BRUXISM 126
589 DRUG LEVEL DECREASED 126
590 ILEUS 126
591 NEUROTOXICITY 126
592 POST-TRAUMATIC STRESS DISORDER 126
593 VENTRICULAR TACHYCARDIA 126
594 VIRAL INFECTION 126
595 BLOOD GLUCOSE ABNORMAL 125
596 DIABETIC COMPLICATION 125
597 POSTURE ABNORMAL 125
598 ANAPHYLACTIC REACTION 124
599 ELECTROENCEPHALOGRAM ABNORMAL 124
600 PREMATURE BABY 124
601 RASH ERYTHEMATOUS 124
602 REBOUND EFFECT 124
603 DYSGEUSIA 123
604 INAPPROPRIATE AFFECT 123
605 PRODUCT STORAGE ERROR 123
606 ALCOHOL ABUSE 122
607 DRUG DISPENSING ERROR 122
608 EMBOLISM VENOUS 122
609 BIPOLAR I DISORDER 121
610 BLOOD GLUCOSE DECREASED 121
611 BONE MARROW FAILURE 121
612 SUICIDAL BEHAVIOUR 121
613 TRISMUS 121
614 BLOOD LACTATE DEHYDROGENASE INCREASED 120
615 BUNDLE BRANCH BLOCK RIGHT 120
616 FLANK PAIN 120
617 MENSTRUAL DISORDER 120
618 MUSCLE TIGHTNESS 120
619 ARTHROPATHY 119
620 FRACTURE 119
621 SUPRAVENTRICULAR TACHYCARDIA 119
622 ACUTE MYOCARDIAL INFARCTION 118
623 AUTONOMIC NERVOUS SYSTEM IMBALANCE 118
624 FLAT AFFECT 118
625 GAZE PALSY 118
626 INCORRECT PRODUCT STORAGE 118
627 INSURANCE ISSUE 118
628 TOXIC EPIDERMAL NECROLYSIS 118
629 ECZEMA 117
630 PRODUCT AVAILABILITY ISSUE 117
631 SKIN DISORDER 117
632 SKIN LESION 117
633 LYMPHADENOPATHY 116
634 RASH PRURITIC 116
635 BONE PAIN 115
636 JOINT STIFFNESS 115
637 BREAST MASS 114
638 CARDIOMEGALY 114
639 TENSION 114
640 TONGUE DISORDER 114
641 DECREASED ACTIVITY 113
642 EAR INFECTION 113
643 INJECTION SITE HAEMORRHAGE 113
644 MALNUTRITION 113
645 KETOACIDOSIS 112
646 PEMPHIGOID 112
647 PERSONALITY DISORDER 112
648 SARCOIDOSIS 112
649 PROCEDURAL COMPLICATION 111
650 SOLILOQUY 111
651 DRUG WITHDRAWAL SYNDROME NEONATAL 110
652 HYPERREFLEXIA 110
653 PARALYSIS 110
654 SUBDURAL HAEMATOMA 110
655 MUCOSAL INFLAMMATION 108
656 MULTIPLE SCLEROSIS RELAPSE 108
657 OCULAR HYPERAEMIA 108
658 BRONCHIECTASIS 107
659 CONJUNCTIVITIS 107
660 DIABETES MELLITUS NON-INSULIN-DEPENDENT 107
661 FEEDING DISORDER 107
662 HOSTILITY 107
663 IMPAIRED SELF-CARE 107
664 WRONG DRUG ADMINISTERED 107
665 DECUBITUS ULCER 106
666 DELUSION OF GRANDEUR 106
667 FEBRILE NEUTROPENIA 106
668 HOT FLUSH 106
669 INITIAL INSOMNIA 106
670 PRODUCT PRESCRIBING ISSUE 106
671 COLITIS ISCHAEMIC 105
672 SENSORY DISTURBANCE 105
673 BLOOD PRESSURE FLUCTUATION 104
674 DEMENTIA ALZHEIMER^S TYPE 104
675 NASAL POLYPS 103
676 NEOPLASM MALIGNANT 103
677 PRODUCTIVE COUGH 103
678 THERMAL BURN 103
679 DYSPHORIA 102
680 GASTROENTERITIS 102
681 PRODUCT COMPLAINT 102
682 GASTRIC ULCER 101
683 MULTIPLE SCLEROSIS 101
684 PHOTOPHOBIA 101
685 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 100
686 FEELING COLD 100
687 HEMIPARESIS 100
688 HIP FRACTURE 100
689 MASTITIS 100
690 PRODUCT CONTAINER ISSUE 100
691 BLOOD GLUCOSE FLUCTUATION 99
692 INJECTION SITE ERYTHEMA 99
693 JOINT INJURY 99
694 ACCIDENTAL EXPOSURE 98
695 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 98
696 EAR PAIN 98
697 LEFT VENTRICULAR DYSFUNCTION 98
698 LIMB DISCOMFORT 98
699 TOTAL LUNG CAPACITY INCREASED 98
700 DYSPHEMIA 97
701 GASTRIC DISORDER 97
702 HAEMORRHOIDS 97
703 HEPATIC ENCEPHALOPATHY 97
704 LIP SWELLING 97
705 RETCHING 97
706 CYSTITIS 96
707 INJECTION SITE MASS 96
708 INTELLECTUAL DISABILITY 96
709 LEUKAEMIA 96
710 TOXIC SKIN ERUPTION 96
711 DECREASED INTEREST 95
712 EYE IRRITATION 95
713 HYPERSEXUALITY 95
714 MYOCARDIAL ISCHAEMIA 95
715 PRESYNCOPE 95
716 EYE SWELLING 94
717 FAECAL INCONTINENCE 94
718 RIB FRACTURE 94
719 APNOEA 93
720 EJECTION FRACTION DECREASED 93
721 HEPATOMEGALY 93
722 MENSTRUATION IRREGULAR 93
723 DELUSIONAL DISORDER, PERSECUTORY TYPE 92
724 FEELING JITTERY 92
725 TACHYPHRENIA 92
726 UROSEPSIS 92
727 BREAST TENDERNESS 91
728 DRUG USE DISORDER 91
729 GAMBLING DISORDER 91
730 MITRAL VALVE INCOMPETENCE 91
731 MUSCULOSKELETAL CHEST PAIN 91
732 SELF-DESTRUCTIVE BEHAVIOUR 91
733 VENTRICULAR FIBRILLATION 91
734 INFERTILITY 90
735 INJECTION SITE SWELLING 90
736 MELAENA 90
737 NOCTURIA 89
738 POTENTIATING DRUG INTERACTION 89
739 PRODUCT PACKAGING QUANTITY ISSUE 89
740 RESPIRATORY TRACT INFECTION 89
741 BLEPHAROSPASM 88
742 BLUNTED AFFECT 88
743 HYPERTHYROIDISM 88
744 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 88
745 IRON DEFICIENCY ANAEMIA 88
746 MICTURITION URGENCY 88
747 THERAPY INTERRUPTED 88
748 TROPONIN INCREASED 88
749 ANURIA 87
750 DENTAL CARIES 87
751 IMPAIRED HEALING 87
752 INTRACRANIAL PRESSURE INCREASED 87
753 END STAGE RENAL DISEASE 86
754 ISCHAEMIC STROKE 86
755 RASH GENERALISED 86
756 TOOTHACHE 86
757 TRICUSPID VALVE INCOMPETENCE 85
758 LIMB INJURY 84
759 PRESCRIBED UNDERDOSE 84
760 SYSTEMIC INFECTION 84
761 AKINESIA 83
762 EOSINOPHIL COUNT DECREASED 83
763 HEAD DISCOMFORT 83
764 LANGUAGE DISORDER 83
765 LONG QT SYNDROME 83
766 NEURALGIA 83
767 OBSESSIVE THOUGHTS 83
768 PULMONARY CONGESTION 83
769 RHEUMATOID ARTHRITIS 83
770 TOOTH LOSS 83
771 COLD SWEAT 82
772 CONDUCTION DISORDER 82
773 FEMUR FRACTURE 82
774 HEPATITIS C 82
775 MULTI-ORGAN FAILURE 82
776 PHYSICAL ASSAULT 82
777 MALIGNANT NEOPLASM PROGRESSION 81
778 MENORRHAGIA 81
779 MUSCLE ATROPHY 81
780 PRODUCT DISPENSING ERROR 81
781 THYROID DISORDER 81
782 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 80
783 ATRIAL SEPTAL DEFECT 80
784 HYPERLACTACIDAEMIA 80
785 JOINT DISLOCATION 80
786 MIDDLE INSOMNIA 80
787 NYSTAGMUS 80
788 SCAR 80
789 BLOOD PRESSURE SYSTOLIC INCREASED 79
790 DISSEMINATED INTRAVASCULAR COAGULATION 79
791 GENERALISED OEDEMA 79
792 HYPOCALCAEMIA 79
793 IMMOBILE 79
794 INJECTION SITE REACTION 79
795 NEUROLOGICAL SYMPTOM 79
796 WRONG PATIENT 79
797 EJACULATION DISORDER 78
798 HEPATIC CIRRHOSIS 78
799 PRODUCT PACKAGING ISSUE 78
800 RESPIRATORY TRACT CONGESTION 78
801 ATRIOVENTRICULAR BLOCK FIRST DEGREE 77
802 CONGESTIVE CARDIOMYOPATHY 77
803 EXTRA DOSE ADMINISTERED 77
804 GLYCOSURIA 77
805 HERPES ZOSTER 77
806 ILLUSION 77
807 INTERVERTEBRAL DISC PROTRUSION 77
808 RENAL FAILURE CHRONIC 77
809 SKIN BURNING SENSATION 77
810 ANAL INCONTINENCE 76
811 CHROMATURIA 76
812 FUNGAL INFECTION 76
813 HAEMOPTYSIS 76
814 HORMONE LEVEL ABNORMAL 76
815 NEUTROPHILIA 76
816 PHARYNGITIS 76
817 PNEUMOTHORAX 76
818 STOMATITIS 76
819 VAGINAL HAEMORRHAGE 76
820 GALLBLADDER DISORDER 75
821 GLAUCOMA 75
822 IRRITABLE BOWEL SYNDROME 75
823 LIVER FUNCTION TEST INCREASED 75
824 PERIPHERAL COLDNESS 75
825 PULMONARY HYPERTENSION 75
826 QUALITY OF LIFE DECREASED 75
827 SCHIZOPHRENIA, PARANOID TYPE 75
828 TOXIC ENCEPHALOPATHY 75
829 ACUTE HEPATIC FAILURE 74
830 BLOOD CHOLESTEROL ABNORMAL 74
831 DEAFNESS 74
832 EOSINOPHIL COUNT INCREASED 74
833 OSTEOPENIA 74
834 PETIT MAL EPILEPSY 74
835 STEREOTYPY 74
836 ATELECTASIS 73
837 BLOOD PRESSURE ABNORMAL 73
838 BRAIN FOG 73
839 BUNDLE BRANCH BLOCK LEFT 73
840 HICCUPS 73
841 IMPAIRED GASTRIC EMPTYING 73
842 NEOPLASM PROGRESSION 73
843 THROAT TIGHTNESS 73
844 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 72
845 ALCOHOLISM 72
846 DYSPNOEA EXERTIONAL 72
847 PANIC DISORDER 72
848 PANIC REACTION 72
849 POLYNEUROPATHY 72
850 APPETITE DISORDER 71
851 ASCITES 71
852 COAGULOPATHY 71
853 COLITIS 71
854 DRUG ABUSER 71
855 INSULIN RESISTANCE 71
856 LABORATORY TEST ABNORMAL 71
857 PAIN IN JAW 71
858 PARKINSONIAN GAIT 71
859 PHOTOSENSITIVITY REACTION 71
860 RESPIRATORY RATE INCREASED 71
861 BLOOD TESTOSTERONE DECREASED 70
862 BONE DENSITY DECREASED 70
863 DIABETES INSIPIDUS 70
864 FACIAL PARALYSIS 70
865 FOOT FRACTURE 70
866 GENERAL PHYSICAL CONDITION ABNORMAL 70
867 HYPERKINESIA 70
868 HYPERVENTILATION 70
869 OLIGURIA 70
870 PERICARDITIS 70
871 THERAPEUTIC AGENT TOXICITY 70
872 BLOOD DISORDER 69
873 DIABETIC RETINOPATHY 69
874 EMBOLISM 69
875 FEELING OF DESPAIR 69
876 IMPRISONMENT 69
877 PROTRUSION TONGUE 69
878 SARS-COV-2 TEST POSITIVE 69
879 ABNORMAL LOSS OF WEIGHT 68
880 ADVERSE REACTION 68
881 ATRIOVENTRICULAR BLOCK 68
882 DRUG SCREEN POSITIVE 68
883 EXTRASYSTOLES 68
884 FIBROMYALGIA 68
885 INTRUSIVE THOUGHTS 68
886 NO THERAPEUTIC RESPONSE 68
887 PSYCHOTIC BEHAVIOUR 68
888 BLOOD CHLORIDE DECREASED 67
889 DEPENDENCE 67
890 DISSOCIATION 67
891 HYPERTENSIVE CRISIS 67
892 INCORRECT DRUG ADMINISTRATION DURATION 67
893 INTENTIONAL DOSE OMISSION 67
894 UPPER GASTROINTESTINAL HAEMORRHAGE 67
895 ACIDOSIS 66
896 DIZZINESS POSTURAL 66
897 IMPAIRED QUALITY OF LIFE 66
898 LEFT VENTRICULAR HYPERTROPHY 66
899 NIGHT SWEATS 66
900 RENAL TUBULAR NECROSIS 66
901 SKIN LACERATION 66
902 ACCIDENTAL DEATH 65
903 COLITIS ULCERATIVE 65
904 MUSCLE SPASTICITY 65
905 RALES 65
906 SPASMODIC DYSPHONIA 65
907 WATER INTOXICATION 65
908 ARTERIOSCLEROSIS 64
909 BODY MASS INDEX INCREASED 64
910 BODY TEMPERATURE DECREASED 64
911 CLOSTRIDIUM DIFFICILE COLITIS 64
912 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 64
913 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 64
914 GASTRIC HAEMORRHAGE 64
915 HIGH DENSITY LIPOPROTEIN DECREASED 64
916 THERAPY CHANGE 64
917 VISUAL DISTURBANCE 64
918 CARPAL TUNNEL SYNDROME 63
919 DERMATITIS 63
920 EXCESSIVE EYE BLINKING 63
921 HYPOACUSIS 63
922 LACERATION 63
923 LYMPHOPENIA 63
924 MALIGNANT CATATONIA 63
925 MUSCLE DISORDER 63
926 PLATELET COUNT INCREASED 63
927 SLOW SPEECH 63
928 ATRIAL FLUTTER 62
929 BACK DISORDER 62
930 BREAST SWELLING 62
931 CROHN^S DISEASE 62
932 FRUSTRATION TOLERANCE DECREASED 62
933 HYPOVOLAEMIA 62
934 BLOOD POTASSIUM INCREASED 61
935 CHOLECYSTITIS 61
936 FLUID INTAKE REDUCED 61
937 HIATUS HERNIA 61
938 LOCALISED INFECTION 61
939 LUNG INFECTION 61
940 MEDICAL DEVICE COMPLICATION 61
941 MUSCLE CONTRACTIONS INVOLUNTARY 61
942 PHARMACEUTICAL PRODUCT COMPLAINT 61
943 PRODUCT LEAKAGE 61
944 SKIN ULCER 61
945 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 60
946 BLOOD URINE PRESENT 60
947 CHOREA 60
948 CYTOLYTIC HEPATITIS 60
949 DEVICE USE CONFUSION 60
950 FOOD CRAVING 60
951 HYDRONEPHROSIS 60
952 MUSCULOSKELETAL DISORDER 60
953 OPISTHOTONUS 60
954 PARKINSON'S DISEASE 60
955 PROTEINURIA 60
956 RASH MACULAR 60
957 RHINALGIA 60
958 BLOOD SODIUM INCREASED 59
959 CACHEXIA 59
960 COMPARTMENT SYNDROME 59
961 DEMENTIA WITH LEWY BODIES 59
962 DEREALISATION 59
963 DIABETIC NEPHROPATHY 59
964 EYELID OEDEMA 59
965 KIDNEY INFECTION 59
966 SELF-MEDICATION 59
967 SPLENOMEGALY 59
968 BLOOD LACTIC ACID INCREASED 58
969 ERYTHEMA MULTIFORME 58
970 HEPATITIS CHOLESTATIC 58
971 HYPERCALCAEMIA 58
972 IMPULSE-CONTROL DISORDER 58
973 SNORING 58
974 SOMNAMBULISM 58
975 URINE OUTPUT DECREASED 58
976 ATRIOVENTRICULAR BLOCK SECOND DEGREE 57
977 CAESAREAN SECTION 57
978 HEPATITIS ACUTE 57
979 LISTLESS 57
980 LYMPHOCYTE COUNT ABNORMAL 57
981 MASTICATION DISORDER 57
982 OESOPHAGITIS 57
983 OSTEONECROSIS 57
984 SINUS ARRHYTHMIA 57
985 SOCIAL PROBLEM 57
986 VENTRICULAR ARRHYTHMIA 57
987 VENTRICULAR SEPTAL DEFECT 57
988 ANKLE FRACTURE 56
989 AREFLEXIA 56
990 CARDIAC FAILURE ACUTE 56
991 CEREBRAL DISORDER 56
992 FEELING GUILTY 56
993 GRANDIOSITY 56
994 INFUSION RELATED REACTION 56
995 INTERVERTEBRAL DISC DEGENERATION 56
996 INTESTINAL HAEMORRHAGE 56
997 MATERNAL DRUGS AFFECTING FOETUS 56
998 METABOLIC ENCEPHALOPATHY 56
999 PRODUCT LABEL ISSUE 56